Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -164,808 | -128,659 | -53,333 | -247,116 | -175,575 |
| Depreciation Amortization | -5,582 | -3,405 | -980 | -340 | 223 |
| Accounts receivable | -3,125 | -6,968 | 2,019 | -21,470 | -13,827 |
| Other Working Capital | -50,501 | -34,302 | -27,658 | -58,945 | -47,187 |
| Other Operating Activity | 137,793 | 107,008 | 32,440 | 166,021 | 98,365 |
| Operating Cash Flow | $-86,223 | $-66,326 | $-47,512 | $-161,850 | $-138,001 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -101,411 | -125,517 | -106,949 | -126,887 | -204,628 |
| PPE Investments | -1,614 | -627 | -160 | -1,351 | -825 |
| Investing Cash Flow | $-103,025 | $-126,144 | $-107,109 | $-128,238 | $-205,453 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 300,000 | 300,000 | N/A | 73,072 | 73,072 |
| Debt Repayment | -261,713 | -261,713 | N/A | N/A | N/A |
| Common Stock Issued | 8,518 | 7,031 | 5,077 | 14,955 | 10,756 |
| Other Financing Activity | -11,147 | -10,885 | 0 | 0 | 0 |
| Financing Cash Flow | $35,658 | $34,433 | $5,077 | $88,027 | $83,828 |
| Exchange Rate Effect | -160 | -413 | -96 | 566 | 235 |
| Beginning Cash Position | 306,239 | 306,239 | 306,239 | 507,734 | 507,734 |
| End Cash Position | 152,489 | 147,789 | 156,599 | 306,239 | 248,343 |
| Net Cash Flow | $-153,750 | $-158,450 | $-149,640 | $-201,495 | $-259,391 |
| Free Cash Flow | |||||
| Operating Cash Flow | -86,223 | -66,326 | -47,512 | -161,850 | -138,001 |
| Capital Expenditure | -1,614 | -627 | -160 | -1,351 | -825 |
| Free Cash Flow | -87,837 | -66,953 | -47,672 | -163,201 | -138,826 |